BridgeBio Pharma (BBIO) Net Cash Flow Growth (3y) (2021 - 2026)
BridgeBio Pharma (BBIO) Net Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
NCF Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
89.97% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-13.44% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
33.37% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
BridgeBio Pharma |
12.90 Bn |
11.97 Bn |
184.58 Mn |
157.14% |
| Date | Value |
|---|
| Mar 31, 2026 |
157.14% |
| Dec 31, 2025 |
-1.92% |
| Sep 30, 2025 |
-115.93% |
| Jun 30, 2025 |
28.39% |
| Mar 31, 2025 |
-85.05% |
| Dec 31, 2024 |
8.89% |
| Sep 30, 2024 |
10.57% |
| Jun 30, 2024 |
40.56% |
| Mar 31, 2024 |
-10.41% |
| Dec 31, 2023 |
-145.82% |
| Sep 30, 2023 |
46.54% |
| Jun 30, 2023 |
20.05% |
| Mar 31, 2023 |
-64.08% |
| Dec 31, 2022 |
-11.13% |
| Sep 30, 2022 |
-52.18% |
| Jun 30, 2022 |
48.12% |
| Mar 31, 2022 |
29.48% |
| Dec 31, 2021 |
-1.64% |
| Sep 30, 2021 |
-69.52% |
